The stock market has seen a flurry of activity recently, with several companies experiencing significant price movements and analyst ratings shifts. Here's a quick rundown of some key developments:
GreenPower Motor Plummets
Shares of GreenPower Motor Company Inc. (OTCMKTS:GPVRF) took a hit on Tuesday, falling by a significant 12.1%. The stock bottomed out at $0.50 before closing at that same price. Trading volume also saw a decrease, with 290,371 shares changing hands, a 28% decline from the average session volume. This downturn marks a notable shift for the company, which had previously closed at $0.57.
Bank of America's Coverage on Titan America
Bank of America has initiated coverage on Titan America (NYSE:TTAM), issuing a 'neutral' rating and setting a price target of $16.50. This objective suggests a potential upside for the stock, according to a research report released to clients and investors on Tuesday. MarketBeat.com was the first to report on this analysis.
Astrana Health's Price Target Lowered
Astrana Health (NASDAQ:ASTH) also saw some action, as Bank of America lowered its price target from $55.00 to $49.00. Despite this reduction, the brokerage maintains a 'buy' rating on the stock, projecting a potential upside of 80.21% from the current price. Benzinga reported on the change.
"While we've adjusted the price target for Astrana Health, our overall outlook remains positive given the potential for growth," stated a Bank of America analyst.
ImmunityBio's Earnings Boost
On a brighter note, ImmunityBio, Inc. (NASDAQ:IBRX) experienced a 6.8% increase in shares during Tuesday's midday trading. This surge followed a stronger-than-expected earnings report. The stock reached a high of $3.01 and last traded at $3.05. While the stock price increased, trading volume decreased by 28% from the daily average.
On Holding AG Gaps Up After Upgrade
On Holding AG (NYSE:ONON) saw its share price jump prior to trading on Tuesday after UBS Group raised their price target from $65.00 to $73.00. The stock, which previously closed at $47.85, opened at $50.84. UBS Group continues to hold a 'buy' rating on the stock, signaling confidence in its future performance. This significant gap up reflects the market's positive reaction to the analyst upgrade.
Finally, in insider trading news, David Cruickshank, an insider at Jupiter Fund Management Plc (LON:JUP), purchased 100,000 shares of the company’s stock on March 4th. The shares were bought at an average price of GBX 74 ($0.95) per share, totaling £74,000 ($95,385.41).